North of England Cancer Network, Cumbria Northumberland Tyne and Wear Area Team, NHS England and GlaxoSmithKline

Joint Working Project

North of England Cancer Network (NECN), Cumbria, Northumberland, Tyne & Wear Area Team, NHS England and GlaxoSmithKline (on behalf of the NECN Pharmaceutical Industry Partnership Group) are engaged in Joint Working to design and develop an Excel-based “New Drug Capacity Calculator” tool that will predict the service impact of new cancer medicines, in terms of healthcare resource utilisation.

Both parties have committed resources to this project which will run until 31st July 2015.

The objective of this Joint Working project is to develop a tool to calculate the impact on capacity of introducing newly approved cancer medicines at NHS Trust, Regional and National level. The aim is to better inform planning and service delivery to NHS patients in the NECN Region, with a view to improving the overall planning and provision of cancer services for patients. GSK will gain an improved understanding of NHS decision making processes and challenges to the uptake of new drugs, which will inform future value propositions for new medicines.

The New Drug Capacity Calculator will support business planning in the NHS and help facilitate a whole system approach to planning for uptake of new medicines. In providing a quick assessment of the capacity impact of new cancer medicines, the tool should improve planning and support quicker decision making.

The tool will calculate the effects of new medicines on capacity and staff resources across the patient pathway and will inform a business case to increase or redeploy such resources if necessary. This should help reduce delays in access to medicines following clinical approval.

Download the New Drug Capacity Calculator from health.gsk

For further information please contact:

Steve Williamson, Consultant Cancer Pharmacist, Cumbria, Northumberland, Tyne & Wear Area Team, NHS England.


GSK UK Customer Contact Centre on 0800 221 441

Note: 'The North of England Cancer Network Pharmaceutical Industry Partnership Group was formed to strengthen links with the Cancer Network and give the important local business relationship between NHS and industry a firm foundation from which to grow and enable sharing of information and skills to the benefit of both parties and cancer patients. The group has undertaken a number of successful joint working projects.'


UK/ONC/0013a/13(3) February 2015